Central venous O₂ saturation and venous-to-arterial CO₂ difference as complementary tools for goal-directed therapy during high-risk surgery

Central venous oxygen saturation (ScvO2) is a useful therapeutic target in septic shock and high-risk surgery. We tested the hypothesis that central venous-to-arterial carbon dioxide difference (P(cv-a)CO2), a global index of tissue perfusion, could be used as a complementary tool to ScvO2 for goal-...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Critical care (London, England) England), 2010-01, Vol.14 (5), p.R193-R193, Article R193
Hauptverfasser: Futier, Emmanuel, Robin, Emmanuel, Jabaudon, Matthieu, Guerin, Renaud, Petit, Antoine, Bazin, Jean-Etienne, Constantin, Jean-Michel, Vallet, Benoit
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page R193
container_issue 5
container_start_page R193
container_title Critical care (London, England)
container_volume 14
creator Futier, Emmanuel
Robin, Emmanuel
Jabaudon, Matthieu
Guerin, Renaud
Petit, Antoine
Bazin, Jean-Etienne
Constantin, Jean-Michel
Vallet, Benoit
description Central venous oxygen saturation (ScvO2) is a useful therapeutic target in septic shock and high-risk surgery. We tested the hypothesis that central venous-to-arterial carbon dioxide difference (P(cv-a)CO2), a global index of tissue perfusion, could be used as a complementary tool to ScvO2 for goal-directed fluid therapy (GDT) to identify persistent low flow after optimization of preload has been achieved by fluid loading during high-risk surgery. This is a secondary analysis of results obtained in a study involving 70 adult patients (ASA I to III), undergoing major abdominal surgery, and treated with an individualized goal-directed fluid replacement therapy. All patients were managed to maintain a respiratory variation in peak aortic flow velocity below 13%. Cardiac index (CI), oxygen delivery index (DO2i), ScvO2, P(cv-a)CO2 and postoperative complications were recorded blindly for all patients. A total of 34% of patients developed postoperative complications. At baseline, there was no difference in demographic or haemodynamic variables between patients who developed complications and those who did not. In patients with complications, during surgery, both mean ScvO2 (78 ± 4 versus 81 ± 4%, P = 0.017) and minimal ScvO2 (minScvO2) (67 ± 6 versus 72 ± 6%, P = 0.0017) were lower than in patients without complications, despite perfusion of similar volumes of fluids and comparable CI and DO2i values. The optimal ScvO2 cut-off value was 70.6% and minScvO2 < 70% was independently associated with the development of postoperative complications (OR = 4.2 (95% CI: 1.1 to 14.4), P = 0.025). P(cv-a)CO2 was larger in patients with complications (7.8 ± 2 versus 5.6 ± 2 mmHg, P < 10-6). In patients with complications and ScvO2 ≥ 71%, P(cv-a)CO2 was also significantly larger (7.7 ± 2 versus 5.5 ± 2 mmHg, P < 10-6) than in patients without complications. The area under the receiver operating characteristic (ROC) curve was 0.785 (95% CI: 0.74 to 0.83) for discrimination of patients with ScvO2 ≥ 71% who did and did not develop complications, with 5 mmHg as the most predictive threshold value. ScvO2 reflects important changes in O2 delivery in relation to O2 needs during the perioperative period. A P(cv-a)CO2 < 5 mmHg might serve as a complementary target to ScvO2 during GDT to identify persistent inadequacy of the circulatory response in face of metabolic requirements when an ScvO2 ≥ 71% is achieved. Clinicaltrials.gov Identifier: NCT00852449.
doi_str_mv 10.1186/cc9310
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3219300</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2231551791</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3730-1bb71ff5d49554364938f64081af556f1670c2dc07b51492bcecc8b8e59d3c9d3</originalsourceid><addsrcrecordid>eNpdkc2KFTEQhRtRnB_1ESS4cFbRpNNJpzeCXPyDgdkouAvppNI3Y3fnWukeuNt5Ap_RJzHjvQ7qoqiC-jicqlNVzzh7xblWr53rBGcPqlPeKEUV674-LLNQDdVSyJPqLOdrxnirlXhcndSciaZp1Wn1YwPzgnYkNzCnNZOrn7e3JNtlRbvENBM7--OKLolaXABjoTe_OR9DAITZAbGZuDTtRpiKnsU9WVIaMwkJyZDsSH1EcAt4smwB7W5P_IpxHsg2DluKMX8jecUBcP-kehTsmOHpsZ9XX96_-7z5SC-vPnzavL2kTrSCUd73LQ9B-qaTsil3dkIH1TDNbZBSBa5a5mrvWNtL3nR178A53WuQnReu1Hn15qC7W_sJvDu8wewwTsW-STaafzdz3Joh3RhR804wVgQujgKYvq-QFzPF7GAc7QzlXUbzmota6aaQL_4jr9OKc7nO6LpuZS3aO7mXB8hhyhkh3FvhzNxFbA4RF_D538bvsT-Zil_MA6Xr</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>822752370</pqid></control><display><type>article</type><title>Central venous O₂ saturation and venous-to-arterial CO₂ difference as complementary tools for goal-directed therapy during high-risk surgery</title><source>MEDLINE</source><source>DOAJ Directory of Open Access Journals</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><source>SpringerLink Journals - AutoHoldings</source><source>Springer Nature OA Free Journals</source><creator>Futier, Emmanuel ; Robin, Emmanuel ; Jabaudon, Matthieu ; Guerin, Renaud ; Petit, Antoine ; Bazin, Jean-Etienne ; Constantin, Jean-Michel ; Vallet, Benoit</creator><creatorcontrib>Futier, Emmanuel ; Robin, Emmanuel ; Jabaudon, Matthieu ; Guerin, Renaud ; Petit, Antoine ; Bazin, Jean-Etienne ; Constantin, Jean-Michel ; Vallet, Benoit</creatorcontrib><description>Central venous oxygen saturation (ScvO2) is a useful therapeutic target in septic shock and high-risk surgery. We tested the hypothesis that central venous-to-arterial carbon dioxide difference (P(cv-a)CO2), a global index of tissue perfusion, could be used as a complementary tool to ScvO2 for goal-directed fluid therapy (GDT) to identify persistent low flow after optimization of preload has been achieved by fluid loading during high-risk surgery. This is a secondary analysis of results obtained in a study involving 70 adult patients (ASA I to III), undergoing major abdominal surgery, and treated with an individualized goal-directed fluid replacement therapy. All patients were managed to maintain a respiratory variation in peak aortic flow velocity below 13%. Cardiac index (CI), oxygen delivery index (DO2i), ScvO2, P(cv-a)CO2 and postoperative complications were recorded blindly for all patients. A total of 34% of patients developed postoperative complications. At baseline, there was no difference in demographic or haemodynamic variables between patients who developed complications and those who did not. In patients with complications, during surgery, both mean ScvO2 (78 ± 4 versus 81 ± 4%, P = 0.017) and minimal ScvO2 (minScvO2) (67 ± 6 versus 72 ± 6%, P = 0.0017) were lower than in patients without complications, despite perfusion of similar volumes of fluids and comparable CI and DO2i values. The optimal ScvO2 cut-off value was 70.6% and minScvO2 &lt; 70% was independently associated with the development of postoperative complications (OR = 4.2 (95% CI: 1.1 to 14.4), P = 0.025). P(cv-a)CO2 was larger in patients with complications (7.8 ± 2 versus 5.6 ± 2 mmHg, P &lt; 10-6). In patients with complications and ScvO2 ≥ 71%, P(cv-a)CO2 was also significantly larger (7.7 ± 2 versus 5.5 ± 2 mmHg, P &lt; 10-6) than in patients without complications. The area under the receiver operating characteristic (ROC) curve was 0.785 (95% CI: 0.74 to 0.83) for discrimination of patients with ScvO2 ≥ 71% who did and did not develop complications, with 5 mmHg as the most predictive threshold value. ScvO2 reflects important changes in O2 delivery in relation to O2 needs during the perioperative period. A P(cv-a)CO2 &lt; 5 mmHg might serve as a complementary target to ScvO2 during GDT to identify persistent inadequacy of the circulatory response in face of metabolic requirements when an ScvO2 ≥ 71% is achieved. Clinicaltrials.gov Identifier: NCT00852449.</description><identifier>ISSN: 1364-8535</identifier><identifier>EISSN: 1466-609X</identifier><identifier>EISSN: 1364-8535</identifier><identifier>DOI: 10.1186/cc9310</identifier><identifier>PMID: 21034476</identifier><language>eng</language><publisher>England: National Library of Medicine - MEDLINE Abstracts</publisher><subject>Aged ; Blood Gas Analysis - methods ; Carbon Dioxide - blood ; Catheterization, Central Venous - methods ; Female ; Fluid Therapy - methods ; Follow-Up Studies ; Humans ; Male ; Middle Aged ; Oxygen - blood ; Patient Care Planning ; Postoperative Complications - blood ; Postoperative Complications - etiology ; Postoperative Complications - therapy ; Risk Factors ; Thoracic Surgical Procedures - adverse effects</subject><ispartof>Critical care (London, England), 2010-01, Vol.14 (5), p.R193-R193, Article R193</ispartof><rights>Copyright National Library of Medicine - MEDLINE Abstracts 2010</rights><rights>Copyright ©2010 Futier et al; licensee BioMed Central Ltd. 2010 Futier et al; licensee BioMed Central Ltd.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3730-1bb71ff5d49554364938f64081af556f1670c2dc07b51492bcecc8b8e59d3c9d3</citedby><cites>FETCH-LOGICAL-c3730-1bb71ff5d49554364938f64081af556f1670c2dc07b51492bcecc8b8e59d3c9d3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3219300/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3219300/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,860,881,27901,27902,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/21034476$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Futier, Emmanuel</creatorcontrib><creatorcontrib>Robin, Emmanuel</creatorcontrib><creatorcontrib>Jabaudon, Matthieu</creatorcontrib><creatorcontrib>Guerin, Renaud</creatorcontrib><creatorcontrib>Petit, Antoine</creatorcontrib><creatorcontrib>Bazin, Jean-Etienne</creatorcontrib><creatorcontrib>Constantin, Jean-Michel</creatorcontrib><creatorcontrib>Vallet, Benoit</creatorcontrib><title>Central venous O₂ saturation and venous-to-arterial CO₂ difference as complementary tools for goal-directed therapy during high-risk surgery</title><title>Critical care (London, England)</title><addtitle>Crit Care</addtitle><description>Central venous oxygen saturation (ScvO2) is a useful therapeutic target in septic shock and high-risk surgery. We tested the hypothesis that central venous-to-arterial carbon dioxide difference (P(cv-a)CO2), a global index of tissue perfusion, could be used as a complementary tool to ScvO2 for goal-directed fluid therapy (GDT) to identify persistent low flow after optimization of preload has been achieved by fluid loading during high-risk surgery. This is a secondary analysis of results obtained in a study involving 70 adult patients (ASA I to III), undergoing major abdominal surgery, and treated with an individualized goal-directed fluid replacement therapy. All patients were managed to maintain a respiratory variation in peak aortic flow velocity below 13%. Cardiac index (CI), oxygen delivery index (DO2i), ScvO2, P(cv-a)CO2 and postoperative complications were recorded blindly for all patients. A total of 34% of patients developed postoperative complications. At baseline, there was no difference in demographic or haemodynamic variables between patients who developed complications and those who did not. In patients with complications, during surgery, both mean ScvO2 (78 ± 4 versus 81 ± 4%, P = 0.017) and minimal ScvO2 (minScvO2) (67 ± 6 versus 72 ± 6%, P = 0.0017) were lower than in patients without complications, despite perfusion of similar volumes of fluids and comparable CI and DO2i values. The optimal ScvO2 cut-off value was 70.6% and minScvO2 &lt; 70% was independently associated with the development of postoperative complications (OR = 4.2 (95% CI: 1.1 to 14.4), P = 0.025). P(cv-a)CO2 was larger in patients with complications (7.8 ± 2 versus 5.6 ± 2 mmHg, P &lt; 10-6). In patients with complications and ScvO2 ≥ 71%, P(cv-a)CO2 was also significantly larger (7.7 ± 2 versus 5.5 ± 2 mmHg, P &lt; 10-6) than in patients without complications. The area under the receiver operating characteristic (ROC) curve was 0.785 (95% CI: 0.74 to 0.83) for discrimination of patients with ScvO2 ≥ 71% who did and did not develop complications, with 5 mmHg as the most predictive threshold value. ScvO2 reflects important changes in O2 delivery in relation to O2 needs during the perioperative period. A P(cv-a)CO2 &lt; 5 mmHg might serve as a complementary target to ScvO2 during GDT to identify persistent inadequacy of the circulatory response in face of metabolic requirements when an ScvO2 ≥ 71% is achieved. Clinicaltrials.gov Identifier: NCT00852449.</description><subject>Aged</subject><subject>Blood Gas Analysis - methods</subject><subject>Carbon Dioxide - blood</subject><subject>Catheterization, Central Venous - methods</subject><subject>Female</subject><subject>Fluid Therapy - methods</subject><subject>Follow-Up Studies</subject><subject>Humans</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Oxygen - blood</subject><subject>Patient Care Planning</subject><subject>Postoperative Complications - blood</subject><subject>Postoperative Complications - etiology</subject><subject>Postoperative Complications - therapy</subject><subject>Risk Factors</subject><subject>Thoracic Surgical Procedures - adverse effects</subject><issn>1364-8535</issn><issn>1466-609X</issn><issn>1364-8535</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpdkc2KFTEQhRtRnB_1ESS4cFbRpNNJpzeCXPyDgdkouAvppNI3Y3fnWukeuNt5Ap_RJzHjvQ7qoqiC-jicqlNVzzh7xblWr53rBGcPqlPeKEUV674-LLNQDdVSyJPqLOdrxnirlXhcndSciaZp1Wn1YwPzgnYkNzCnNZOrn7e3JNtlRbvENBM7--OKLolaXABjoTe_OR9DAITZAbGZuDTtRpiKnsU9WVIaMwkJyZDsSH1EcAt4smwB7W5P_IpxHsg2DluKMX8jecUBcP-kehTsmOHpsZ9XX96_-7z5SC-vPnzavL2kTrSCUd73LQ9B-qaTsil3dkIH1TDNbZBSBa5a5mrvWNtL3nR178A53WuQnReu1Hn15qC7W_sJvDu8wewwTsW-STaafzdz3Joh3RhR804wVgQujgKYvq-QFzPF7GAc7QzlXUbzmota6aaQL_4jr9OKc7nO6LpuZS3aO7mXB8hhyhkh3FvhzNxFbA4RF_D538bvsT-Zil_MA6Xr</recordid><startdate>20100101</startdate><enddate>20100101</enddate><creator>Futier, Emmanuel</creator><creator>Robin, Emmanuel</creator><creator>Jabaudon, Matthieu</creator><creator>Guerin, Renaud</creator><creator>Petit, Antoine</creator><creator>Bazin, Jean-Etienne</creator><creator>Constantin, Jean-Michel</creator><creator>Vallet, Benoit</creator><general>National Library of Medicine - MEDLINE Abstracts</general><general>BioMed Central</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>K9.</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20100101</creationdate><title>Central venous O₂ saturation and venous-to-arterial CO₂ difference as complementary tools for goal-directed therapy during high-risk surgery</title><author>Futier, Emmanuel ; Robin, Emmanuel ; Jabaudon, Matthieu ; Guerin, Renaud ; Petit, Antoine ; Bazin, Jean-Etienne ; Constantin, Jean-Michel ; Vallet, Benoit</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3730-1bb71ff5d49554364938f64081af556f1670c2dc07b51492bcecc8b8e59d3c9d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>Aged</topic><topic>Blood Gas Analysis - methods</topic><topic>Carbon Dioxide - blood</topic><topic>Catheterization, Central Venous - methods</topic><topic>Female</topic><topic>Fluid Therapy - methods</topic><topic>Follow-Up Studies</topic><topic>Humans</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Oxygen - blood</topic><topic>Patient Care Planning</topic><topic>Postoperative Complications - blood</topic><topic>Postoperative Complications - etiology</topic><topic>Postoperative Complications - therapy</topic><topic>Risk Factors</topic><topic>Thoracic Surgical Procedures - adverse effects</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Futier, Emmanuel</creatorcontrib><creatorcontrib>Robin, Emmanuel</creatorcontrib><creatorcontrib>Jabaudon, Matthieu</creatorcontrib><creatorcontrib>Guerin, Renaud</creatorcontrib><creatorcontrib>Petit, Antoine</creatorcontrib><creatorcontrib>Bazin, Jean-Etienne</creatorcontrib><creatorcontrib>Constantin, Jean-Michel</creatorcontrib><creatorcontrib>Vallet, Benoit</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Critical care (London, England)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Futier, Emmanuel</au><au>Robin, Emmanuel</au><au>Jabaudon, Matthieu</au><au>Guerin, Renaud</au><au>Petit, Antoine</au><au>Bazin, Jean-Etienne</au><au>Constantin, Jean-Michel</au><au>Vallet, Benoit</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Central venous O₂ saturation and venous-to-arterial CO₂ difference as complementary tools for goal-directed therapy during high-risk surgery</atitle><jtitle>Critical care (London, England)</jtitle><addtitle>Crit Care</addtitle><date>2010-01-01</date><risdate>2010</risdate><volume>14</volume><issue>5</issue><spage>R193</spage><epage>R193</epage><pages>R193-R193</pages><artnum>R193</artnum><issn>1364-8535</issn><eissn>1466-609X</eissn><eissn>1364-8535</eissn><abstract>Central venous oxygen saturation (ScvO2) is a useful therapeutic target in septic shock and high-risk surgery. We tested the hypothesis that central venous-to-arterial carbon dioxide difference (P(cv-a)CO2), a global index of tissue perfusion, could be used as a complementary tool to ScvO2 for goal-directed fluid therapy (GDT) to identify persistent low flow after optimization of preload has been achieved by fluid loading during high-risk surgery. This is a secondary analysis of results obtained in a study involving 70 adult patients (ASA I to III), undergoing major abdominal surgery, and treated with an individualized goal-directed fluid replacement therapy. All patients were managed to maintain a respiratory variation in peak aortic flow velocity below 13%. Cardiac index (CI), oxygen delivery index (DO2i), ScvO2, P(cv-a)CO2 and postoperative complications were recorded blindly for all patients. A total of 34% of patients developed postoperative complications. At baseline, there was no difference in demographic or haemodynamic variables between patients who developed complications and those who did not. In patients with complications, during surgery, both mean ScvO2 (78 ± 4 versus 81 ± 4%, P = 0.017) and minimal ScvO2 (minScvO2) (67 ± 6 versus 72 ± 6%, P = 0.0017) were lower than in patients without complications, despite perfusion of similar volumes of fluids and comparable CI and DO2i values. The optimal ScvO2 cut-off value was 70.6% and minScvO2 &lt; 70% was independently associated with the development of postoperative complications (OR = 4.2 (95% CI: 1.1 to 14.4), P = 0.025). P(cv-a)CO2 was larger in patients with complications (7.8 ± 2 versus 5.6 ± 2 mmHg, P &lt; 10-6). In patients with complications and ScvO2 ≥ 71%, P(cv-a)CO2 was also significantly larger (7.7 ± 2 versus 5.5 ± 2 mmHg, P &lt; 10-6) than in patients without complications. The area under the receiver operating characteristic (ROC) curve was 0.785 (95% CI: 0.74 to 0.83) for discrimination of patients with ScvO2 ≥ 71% who did and did not develop complications, with 5 mmHg as the most predictive threshold value. ScvO2 reflects important changes in O2 delivery in relation to O2 needs during the perioperative period. A P(cv-a)CO2 &lt; 5 mmHg might serve as a complementary target to ScvO2 during GDT to identify persistent inadequacy of the circulatory response in face of metabolic requirements when an ScvO2 ≥ 71% is achieved. Clinicaltrials.gov Identifier: NCT00852449.</abstract><cop>England</cop><pub>National Library of Medicine - MEDLINE Abstracts</pub><pmid>21034476</pmid><doi>10.1186/cc9310</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1364-8535
ispartof Critical care (London, England), 2010-01, Vol.14 (5), p.R193-R193, Article R193
issn 1364-8535
1466-609X
1364-8535
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3219300
source MEDLINE; DOAJ Directory of Open Access Journals; EZB-FREE-00999 freely available EZB journals; PubMed Central; Alma/SFX Local Collection; SpringerLink Journals - AutoHoldings; Springer Nature OA Free Journals
subjects Aged
Blood Gas Analysis - methods
Carbon Dioxide - blood
Catheterization, Central Venous - methods
Female
Fluid Therapy - methods
Follow-Up Studies
Humans
Male
Middle Aged
Oxygen - blood
Patient Care Planning
Postoperative Complications - blood
Postoperative Complications - etiology
Postoperative Complications - therapy
Risk Factors
Thoracic Surgical Procedures - adverse effects
title Central venous O₂ saturation and venous-to-arterial CO₂ difference as complementary tools for goal-directed therapy during high-risk surgery
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T15%3A11%3A41IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Central%20venous%20O%E2%82%82%20saturation%20and%20venous-to-arterial%20CO%E2%82%82%20difference%20as%20complementary%20tools%20for%20goal-directed%20therapy%20during%20high-risk%20surgery&rft.jtitle=Critical%20care%20(London,%20England)&rft.au=Futier,%20Emmanuel&rft.date=2010-01-01&rft.volume=14&rft.issue=5&rft.spage=R193&rft.epage=R193&rft.pages=R193-R193&rft.artnum=R193&rft.issn=1364-8535&rft.eissn=1466-609X&rft_id=info:doi/10.1186/cc9310&rft_dat=%3Cproquest_pubme%3E2231551791%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=822752370&rft_id=info:pmid/21034476&rfr_iscdi=true